The role of extent of resection in gliosarcoma compared to glioblastoma—A volumetric matched-cohort assessment of residual contrast-enhancing tumor
Neuro-Oncology Advances · 12.01.2026 · 8 (1)
DOI: 10.1093/noajnl/vdag235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 10.11.2026. Verfasst von Obada T Alhalabi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Heidelberg University Hospital, Ruprecht-Karl-University, Heidelberg, Germany. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heidelberg University Medical Faculty Clinician-Scientist-Program.
Abstract (Originalsprache)
Background
The extent of resection (EOR) of contrast-enhancing tumor is an established determinant of survival in glioblastoma (GB). However, its prognostic role in gliosarcoma (GS), a histopathologically distinct GB subtype, remains poorly characterized. This study investigated the influence of EOR on survival in GS compared to GB.
Methods
In this retrospective study, we analyzed clinical, surgical, and volumetric MRI data—including early postoperative MRI (within 48 h)—from patients undergoing resection for histopathologically confirmed primary GS between 2007 and 2023. A cohort of 130 GB patients served as a reference. Patients developing GS upon recurrence of primary GB were excluded.
Results
Of 63 patients screened, 49 met the inclusion criteria. Gliosarcoma patients presented with significantly larger mean preoperative contrast-enhancing tumor volumes than GB patients (32.1 vs 22.4 mL, P = .021), yet achieved comparable rates of gross total resection (mean residual tumor volume: 0.09 vs 0.12 mL, P = .435). Median overall survival was 720 days in GS and 648 days in GB patients. Complete resection (0 mL residual tumor) conferred a more pronounced survival benefit in GS than GB: median overall survival was 720 vs 402 days for GS patients with 0 mL vs >0-1 mL residual tumor (P = .022), compared to 713 vs 510 days in GB (P = .042). A matched cohort analysis (n = 54) confirmed this differential benefit.
Conclusions
Complete resection may confer a greater survival benefit in GS than in GB, suggesting that EOR influences prognosis differently in this histopathologically distinct subtype and supporting a tailored surgical approach to GS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Heidelberg University Hospital, Ruprecht-Karl-University, Heidelberg, Germany.
- Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
- Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.
- Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
ORCID-Profile: Obada T Alhalabi, Philipp Sievers, Christel Herold-Mende, Marianne Schell, Tobias Kessler, Felix Sahm, Bogdana Suchorska
Förderung
- Heidelberg University Medical Faculty Clinician-Scientist-Program
Zitieren
APA
Alhalabi, O. T., Sievers, P., Kaes, M., Abo Arab, A. G., Mironov, K., Oldashi, H., Gareib, A. N., Krämer, J., Herold-Mende, C., Schell, M., Kessler, T., Sahm, F., Suchorska, B., Krieg, S. M., & Ille, S. (2026). The role of extent of resection in gliosarcoma compared to glioblastoma—A volumetric matched-cohort assessment of residual contrast-enhancing tumor. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag235
Vancouver
Alhalabi OT, Sievers P, Kaes M, Abo Arab AG, Mironov K, Oldashi H, et al. The role of extent of resection in gliosarcoma compared to glioblastoma—A volumetric matched-cohort assessment of residual contrast-enhancing tumor. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag235
BibTeX
@article{Alhalabi2026,
author = {Alhalabi, Obada T and Sievers, Philipp and Kaes, Manuel and Abo Arab, Ahmad Gamal and Mironov, Kirill and Oldashi, Henri and Gareib, Ahmed Nor and Krämer, Johanna and Herold-Mende, Christel and Schell, Marianne and Kessler, Tobias and Sahm, Felix and Suchorska, Bogdana and Krieg, Sandro M and Ille, Sebastian},
title = {The role of extent of resection in gliosarcoma compared to glioblastoma—A volumetric matched-cohort assessment of residual contrast-enhancing tumor},
journal = {Neuro-Oncology Advances},
year = {2026},
volume = {8},
number = {1},
doi = {10.1093/noajnl/vdag235}
}
EUVIMED